Skip to content

Clinical trials

Bone Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases Country / region: United States Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20041
20084
20094
20105
20115
20127
20132
20148
20153
20163
20172
20183
20195
20203
20215
20221
20233
20244
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting11
Terminated7
Active, not recruiting7
Unknown status4
Enrolling by invitation4
Not yet recruiting2
No longer available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.11
BioMarin Pharmaceutical9
QED Therapeutics, a BridgeBio company8
National Institute of Dental and Craniofacial Research (NIDCR)4
Northwestern University4
Amgen3
Johns Hopkins University2
Massachusetts General Hospital2
Mayo Clinic2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases85
Musculoskeletal Diseases37
Dwarfism16
Osteochondrodysplasias15
Genetic Diseases, Inborn14
Achondroplasia13
Rickets13
Osteomalacia12
Hypophosphatasia11
Bone Diseases, Metabolic10

Trials

Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.